PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-1878

  1. 594 Posts.
    lightbulb Created with Sketch. 135
    Wow, thank you for posting.

    I need to hear things like this from time to time to keep my conviction. For sure, the last 12 months have been trying, but Scott's thesis that iPPS could be the go to drug for lysosomal and other inflammatory diseases could play out.

    We all know how important the relationship/collaboration with Bene is and this video just reinforces it even more.

    Looking forward to the quarterly update - revenues, MPS updates and hopefully IND open. Bring on Monday (if not earlier).
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $85.80M
Open High Low Value Volume
28.0¢ 29.0¢ 24.0¢ $969.3K 3.648M

Buyers (Bids)

No. Vol. Price($)
6 34182 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 24689 1
View Market Depth
Last trade - 16.10pm 18/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.